Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00668447 · ClinicalTrials.gov registry record · Phase 4

Soy and Isoflavones Effect on Bone

A Phase 4 study, sponsored by United States Department of Agriculture (USDA).

Completed
Registry status
Phase 4
Development phase
97
Enrollment target

NCT00668447 is a Phase 4 study that has completed, run by United States Department of Agriculture (USDA). The registered enrollment target is 97 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00668447, a Phase 4 study, has completed, sponsored by United States Department of Agriculture (USDA).

COMPLETED
Registry status
Phase 4
Development phase
97 participants
Enrollment target

Study Summary

The purpose of this study is to test the effect of 1 year of added dietary soy protein and/or soy isoflavones on bone mineral density in late postmenopausal women.

Interventions

  • DIETARY_SUPPLEMENT Placebo tablets
  • DIETARY_SUPPLEMENT Control protein
  • DIETARY_SUPPLEMENT Soy Isolate
  • DIETARY_SUPPLEMENT Novasoy isoflavones

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2001-11
Est. Completion 2005-06
Phase Phase 4

What the Registry Record Tells You About NCT00668447

The ClinicalTrials.gov registry entry for NCT00668447 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Department of Agriculture (USDA), which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Placebo tablets is the first listed.

NCT00668447 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00668447 about?

NCT00668447 is a clinical study titled "Soy and Isoflavones Effect on Bone". The purpose of this study is to test the effect of 1 year of added dietary soy protein and/or soy isoflavones on bone mineral density in late postmenopausal women.

What is the current status of trial NCT00668447?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 97 participants. The study started on 2001-11. Estimated completion is 2005-06.

What interventions are being tested in trial NCT00668447?

The interventions under investigation include: Placebo tablets (DIETARY_SUPPLEMENT), Control protein (DIETARY_SUPPLEMENT), Soy Isolate (DIETARY_SUPPLEMENT), Novasoy isoflavones (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00668447?

This trial is sponsored by United States Department of Agriculture (USDA), which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.